Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.090
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
2.055
-0.035 (-1.67%)
After-hours: May 12, 2025, 4:57 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $57.94 million as of May 12, 2025. Its market cap has increased by 3.05% in one year.
Market Cap
57.94M
Enterprise Value
43.08M
1-Year Change
3.05%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $57.94M, a decrease of -11.87%. That is a compound annual growth rate of -3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 57.94M | -4.26% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.58B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.31B |
| AbbVie | 337.09B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.48B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |